PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

European shares sink on Ukraine jitters, weak earnings

Tue, 01st Mar 2022 17:31

March 1 (Reuters) - European stocks tumbled on Tuesday, kicking off March on a dour note on weak earnings reports and jitters over the Ukraine crisis as Russia raged on with its attack after ceasefire talks between the two nations failed to reach a breakthrough.

Oil prices were back above $100 per barrel and gold, bonds and the dollar surged as investors fled to safe havens.

Italy's financials-heavy benchmark sank 4.1% as banks lost 6.8%, while a slide in luxury names saw France's CAC 40 drop 3.9% and hit over five-month lows.

The indexes deepened recent losses as Russian rained down rockets in Ukrainian cities after ceasefire talks between Russia and its southern neighbour failed to reach a breakthrough on Monday.

Stock markets across the globe plunged on Monday after the West imposed tough sanctions on Russia, including preventing its central bank from using its $630 billion foreign reserve war chest.

"For Europe, the downside risks exceed upside at this point because the conflict is still raging on... Sentiment is still going to remain down in the dumps," said Craig Erlam, senior analyst at Oanda.

The pan-European STOXX 600 index dropped 1.7%, but a rally in healthcare and miners helped limit losses.

The travel and leisure sector dropped the most, down 7.5% after disappointing earnings from betting group Flutter .

"The combination of soaring oil prices and energy costs combined with the impact of sanctions that are being imposed and closing of airspace are all significant headwinds as far as airlines and travel are concerned," Erlam said.

Energy major Shell and shipping firm Maersk slipped on cutting Russia exposure and halting operations, respectively.

Shares in pandemic winners including German online fashion retailer Zalando and meal-kit delivery firm HelloFresh dropped 9.6% and 7.8% respectively after downbeat profit forecasts.

Germany's DAX index slid 3.9%.

Europe Inc profits are expected to have risen 67.4% in the fourth quarter of 2021, data from Refinitiv I/B/E/S showed on Tuesday, as higher oil and gas prices boost the energy sector.

Meanwhile, IHS Markit's survey showed momentum in euro zone manufacturing growth waned slightly last month but activity was still strong and supply chain constraints eased.

German chemicals maker Covestro gained 2.3% after saying it had more than doubled its 2021 core profit and expected upbeat earnings for 2022.

Rheinmetall topped the STOXX 600 to extend gains on the prospect of a big boost to military spending in Germany. Its shares have surged close to 70% in the past six sessions.

Drugmaker AstraZeneca rose 1.8% on a $760 mln deal for an antibody-based drug with Swiss firm Neurimmune. (Reporting by Sruthi Shankar in Bengaluru; Editing by Subhranshu Sahu, Vinay Dwivedi and Andrea Ricci)

More News
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more
2 Jan 2024 12:01

LONDON MARKET MIDDAY: London stocks make largely soft start to 2024

(Alliance News) - Stock prices in London were mostly lower at midday on Tuesday in a slow start to the new year, reacting to the UK manufacturing sector finishing a tricky 2023 with a further contraction in December.

Read more
2 Jan 2024 11:00

Weight-loss drugs: Who, and what, are they good for?

Jan 2 (Reuters) - Powerful weight-loss medicines like Novo Nordisk's Wegovy leapt into public view in 2023, from social media to doctors' offices and cocktail parties, offering a new way to address record obesity rates.

Read more
2 Jan 2024 11:00

What other health conditions might weight-loss drugs treat?

Jan 2 (Reuters) - Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.

Read more
2 Jan 2024 08:48

LONDON MARKET OPEN: New Year begins largely green amid slew of PMIs

(Alliance News) - Stock prices in London opened mostly up on Tuesday, the first day of trading in 2024, reacting to slightly improved factory activity in China, with more manufacturing PMIs from major economies due.

Read more
2 Jan 2024 08:26

AstraZeneca and Sanofi received approval in China for RSV antibody

(Alliance News) - AstraZeneca PLC and Sanofi SA's long-acting monoclonal antibody Beyfortus received approval for use in China to prevent respiratory syncytial virus disease, Astra said on Tuesday.

Read more
2 Jan 2024 07:57

LONDON BRIEFING: AstraZeneca, Sanofi's RSV treatment approved in China

(Alliance News) - Stock prices in London are expected to open higher on Tuesday, reacting to a slight expansion in manufacturing activity in China and ahead of a slew of manufacturing PMI data including for the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.